BioRestorative Therapies company info

What does BioRestorative Therapies do?
BioRestorative Therapies (NASDAQ:BRTX) focuses on developing products and therapies using cell and tissue protocols, primarily aimed at addressing unmet medical needs. Their operations cover a broad spectrum of developmental projects, such as innovative treatments for metabolic disorders and disc/spine disease management through their ThermoStem® and brtxDISC™ programs. BioRestorative Therapies’ objective is to pioneer in the sphere of regenerative medicine by advancing these programs to commercial stages, thereby offering new therapeutic options to patients and the broader healthcare community. With a commitment to scientific excellence and innovation, the company seeks to improve the quality of life for individuals suffering from conditions that currently have limited treatment options.
BioRestorative Therapies company media
Company Snapshot

Is BioRestorative Therapies a public or private company?

key
Ownership
Public

How many people does BioRestorative Therapies employ?

people
Employees
11

What sector is BioRestorative Therapies in?

pie chart
Sector
Health Care

Where is the head office for BioRestorative Therapies?

location pin
Head Office
Melville, United States

What year was BioRestorative Therapies founded?

founded flag
Year Founded
1997
What does BioRestorative Therapies specialise in?
/Stem Cell Therapy /Metabolic Disorders Treatment /Disc/Disc-related Degeneration /Chronic Back Pain /ThermoStem Program /Medical Research

What are the products and/or services of BioRestorative Therapies?

Overview of BioRestorative Therapies offerings
ThermoStem is a program using brown adipose tissue-derived stem cells to potentially treat metabolic disorders including diabetes and obesity.
BRTX-100 is a product developed for treating chronic lumbar disc disease using a patient's own stem cells.
A hair restoration project focuses on developing methods to regenerate hair using stem cell technology.
Research in developing biological solutions to repair disc spine without the need for surgical intervention.
Engagement in developing therapies for osteoarthritis and other musculoskeletal diseases based on stem cell and tissue engineering techniques.

Who is in the executive team of BioRestorative Therapies?

BioRestorative Therapies leadership team
  • Mr. Lance  Alstodt
    Mr. Lance Alstodt
    Chairman of the Board, President & CEO
  • Mr. Robert Eugene Kristal
    Mr. Robert Eugene Kristal
    Chief Financial Officer
  • Mr. Francisco J. Silva
    Mr. Francisco J. Silva
    Chief Scientist, VP of Research & Development, Secretary and Director
  • Mr. Robert  Paccasassi
    Mr. Robert Paccasassi
    Vice President of Quality Assurance & Regulatory Compliance
  • Dr. Wayne J. Olan M.D.
    Dr. Wayne J. Olan M.D.
    Clinical Director of Regenerative Disc & Spine Program and Member of Scientific Advisory Board